Exhibit 10.4
Form 8-K
Immunotechnology Corporation
File No. 0-24641
                                 PROMISSORY NOTE

Principal Amount: $10,000.00

     For  value  received,   the  undersigned,   ImmunoTechnology   Corporation,
("Borrower"),  promises to pay to Steve Scharmann,  ("Lender"), or to his order,
at any location so designated by Lender, in lawful money of the United States of
America, the total principal amount outstanding on this Note ("Note"),  together
with  interest  in the  amount of 10% per annum on the  unpaid  balance  of said
principal. In addition, Borrower will issue an option to purchase 100,000 shares
of the common stock of ImmunoTechnology Corporation at a price of $.01 per share
for a period  of two years  from the date of this  Note.  Number  of shares  and
exercise price shall be adjusted proportionally in the event of a stock split.

     Should the rate of interest as  calculated  exceed that allowed by law, the
applicable  rate of  interest  will be the  maximum  rate of  interest  lawfully
allowed.

     The principal amount outstanding and accrued interest on this Note shall be
due and payable in full on:

            November 23, 2004  (90 days).

     If Borrower  fails to make any  scheduled  payment on this Note when due or
otherwise defaults in any other obligations imposed by this Note, or by any Loan
Agreement,  Security  Agreement or any  document  which  secures this Note,  the
Lender, at its option, may declare  immediately due and payable all amounts then
due on this Note,  or any other note secured by  collateral  securing this Note.
Lender  shall have all rights of offset  against  any  account  or  property  of
Borrower held by Lender.  Borrower shall pay all costs and expenses  incurred by
the Lender or by any other holder of this Note in connection with any failure to
pay or other default of Borrower,  including attorney's fees,  collection costs,
court costs, and costs on appeal, whether incurred before or after judgement.

      This Note is to be construed under the laws of the State of Utah.

     The makers,  sureties,  guarantors  and  endorsers of this Note jointly and
severally waive presentment for payment,  protest, notice of protest, and notice
of non-payment of this Note, and consent that this Note or any payment due under
this Note may be extended or renewed without prior demand or notice, and further
consent  to the  release  of any  collateral  or part  thereof,  with or without
substitution.

      Dated: August 25, 2004

      ImmunoTechnology Corporation


      /s/Mark A. Scharmann
      President/Director